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The purpose of this study was to differentiate between 
asthmatics whose daily symptoms are related to daily stress 
level (stress responders) and those whose symptoms have no 
apparent relation to stress (stress nonresponders) and to 
identify differences between the two groups. Using 
correlational procedures, 15 stress responders and 19 
stress nonresponders were identified and compared along 
various dimensions. Multivariate analysis of variance 
(MANOVA) and covariance (MANCOVA) procedures revealed no 
significant differences between the two groups with respect 
to affective/emotional responding, clinical symptomatology, 
or cognitions about illness and asthma. In addition, 
regression models using the Asthma Symptom Checklist Panic- 
Fear subscale, a measure of depression, and a measure of 
anxiety were unable to successfully predict asthma symptom 
severity. Discriminant analyses also showed that these 
variables were unable to successfully differentiate between 
the two groups. These results call into question the 
validity of the responder/nonresponder distinction. There 
is a need however, for a more comprehensive assessment 
measuring physiological, psychophysiological, and other 
dimensions of responding before abandoning research on this 




Bronchial asthma is a chronic, disabling disorder 
affecting many Americans. Epidemiological data indicate 
that 8.9 million Americans are afflicted with the disease 
(NIAID Task Force, 1979). Approximately 7% of the total 
population either has had asthma in the past or is 
currently afflicted. The financial burden of the disease 
is enormous. The total costs directly attributable to 
asthma have been estimated to be $1.3 billion per year 
(Cooper, 1976). In attempting to manage this disease, 
families typically spend 2-30% of their total income (Vance 
& Taylor, 1971). Thus, at times, the financial burden can 
be overwhelming.
In addition to being financially handicapping, asthma 
is extremely disabling. Problems related to asthma result 
in 27 million physician visits per year (Davis, 1972). In 
children under age 17, asthma represents the leading cause 
of activity restriction (National Center for Health 
Statistics, 1971). Approximately 7 million school days per 
year are lost to asthma (Davis, 1972). This represents 
about 25% of the total number of school days lost (Schiffer 
& Hunt, 1963). In adults, the effects are just as 
dramatic. Asthma accounts for the loss of 5 million work
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days per year (Davis, 1972). In addition, many individuals 
may be limited in the type of occupation they may choose to 
pursue and may be limited in where they can live (Rainwater 
& Alexander, 1982). Asthma is very disruptive to the 
overall functioning of families, and the lives of family 
members often revolve around the patient's illness. Asthma 
has even been linked to the occurrence of divorce (NIAID,
1979). Therefore, in addition to the many economic burdens 
placed on asthmatics, this disease has a major impact upon 
their quality of life and may directly affect interpersonal 
relationships.
Because of the substantial economic burdens of asthma 
and the adverse effects it has on a patient's quality of 
life, much research has been generated in an effort to 
establish the causes of asthma and appropriate treatments. 
Research has discovered that the basic physiological defect 
in asthma is hyperreactivity of the bronchial muscles 
(Curry, 1946). This hyperreactivity is an inherited 
characteristic (Bronsky & Ellis, 1969). However, 
environmental stimuli can also induce bronchial 
hyperreactivity. In fact, hyperreactivity of the bronchial 
muscles can result simply from the recurrence of 
bronchospasms (Burrows, 1979).
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An asthma attack occurs when certain provocative 
stimuli are encountered by an individual with hyperreactive 
airways (Van Arsdel, 1985). A variety of provocative 
stimuli have been implicated including specific allergens 
and irritant particles (e.g. dust), bronchial infections, 
certain pharmacologic agents, psychological factors, and 
vigorous exercise (Reed, 1975). Inhaled allergens are some 
of the most prominent factors. They typically produce an 
immediate allergic reaction in the airways resulting in 
bronchoconstriction. This bronchoconstriction is the 
result of the release of chemical mediators by mast cells 
located in the bronchi (Austin & Orange, 1975; Henderson & 
Kaliner, 1978; Matte, 1976; Parker, 1979). The specific 
chemical mediators important in the production of asthmatic 
symptoms are still undetermined.
The primary pharmacologic agents that frequently 
produce asthma attacks are, not surprisingly, 
bronchoconstrictors. Asthmatic individuals are much more 
susceptible to bronchoconstrictor medication than are 
normal individuals and thus, respiratory responses to 
bronchoconstrictor agents are often used as a measure of 
bronchial reactivity (Benson, 1975). Additionally, 
aspirin, beta blocker medications, and certain foods,
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especially those with yellow coloring agents, may induce 
bronchoconstriction in an asthmatic (Aaronson, 1980).
Despite the fact that there are potentially many 
medical causes, psychological factors have been implicated 
for many years. Depression is frequently cited as a common 
associated symptom (Thompson & Thompson, 1984), but its 
role as a possible etiological factor is unclear. Anxiety 
and stress have long been considered to play a major 
etiological role in asthma as well as being a consequent of 
having the disease (Rainwater & Alexander, 1982). Several 
studies have been designed to validate the role of these 
factors. Definitive conclusions have been impossible to 
make, however, because of numerous inconsistencies within 
the relevant literature (Spittle & Sears, 1984). While 
some studies find evidence in favor of anxiety as a 
possible etiological factor (e.g., Dekker, Barendregy, & De 
Vries, 1961), others have not (e.g., Rosenthal, Aitken, & 
Zealley, 1973).
Most of the stress studies have indicated that a 
positive association between stress and asthma symptom 
severity exists, but inconsistencies within some studies 
have led to the postulation that while a subsample of 
asthmatics may respond to stress with increased breathing 
difficulties, many others may be essentially unaffected by
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stressful situations (Kinsman, Dirks, Jones, & Dahlem,
1980). This paper reviews the relevant literature with 
regard to stress, anxiety, and asthma, and proposes a study 
designed to test for possible differences in various 
aspects of functioning between those identified as stress 
responder asthmatics and those asthmatics found to be 
unresponsive to stress.
Medical Management of Asthma
The physical symptoms of an asthma attack include 
wheezing (the cardinal symptom), coughing, dyspnea, and 
cyanosis. Treatment of an acute asthma attack is usually 
through the use of bronchodilators (Fischl, 1985).
However, more severe attacks often require treatment with 
steroids as well. Although these palliative treatments are 
usually effective in alleviating the acute attack, therapy 
with asthmatics is primarily preventive, because a 
prolonged remission is often helpful in reducing the 
occurrence of future attacks, partly because of a reduction 
in the.reactivity of the airways (Burrows, 1979).
One of the primary preventive measures is to avoid 
contact with stimuli that elicit asthma attacks (Hackney & 
Linn, 1985). Certain stimuli aggravate most asthmatics. 
These include tobacco smoke and dust. In addition, some 
individuals may respond to other specific stimuli as well.
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However, the identification of specific allergens is very 
difficult and time consuming, and the reliability of the 
tests used to determine specific sensitivities is 
questionable (Merrett & Merrett, 1979; Vanto, 1982). Even 
if specific allergens are identified, avoidance of the 
stimuli may not be a viable alternative, either because of 
the nature and ubiquity of the stimuli or because of the 
number of stimuli to which an individual may be sensitive. 
In some individuals for whom relatively few stimuli are 
responsible for the majority of the attacks, immunotherapy 
(also referred to as hyposensitization or antiallergic 
therapy) may be attempted (Lichtenstein, 1978). This 
therapy consists of injecting progressively larger amounts 
of the allergen to which the individual is sensitive such 
that the body can slowly build up antibodies to counteract 
the effects of the allergen. However, this type of 
treatment is very expensive, takes several weeks to 
complete, and the efficacy of this procedure has yet to be 
established (Knauer, Kagey-Sobotka, & Lichtenstein, 1985).
Given the above problems, the primary mode of 
treatment has been pharmacotherapy, and the main type of 
medication used is the class of drugs known as 
bronchodilators (Burrows, 1979). These medications have 
their effectiveness because they inhibit the production of
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chemical mediators and reduce bronchial muscle 
contractility. These medications are frequently abused, 
however, often resulting in a refractoriness to the 
medication and in potentially dangerous cardiac arrythmias 
(Alberts & Moser, 1985). When bronchodilators are not 
effective in preventing the recurrence of attacks, 
adrenocortical hormones (i.e. steroids) are occasionally 
used (Hahn & Harding, 1980). Generally, steroids are given 
for only a few days. Some asthmatics, however, due to the 
severity of their problems must remain on steroids in order 
to maintain pulmonary functioning reasonably close to 
normal (Fallers & Ellis, 1965). Another medication used 
occasionally in the prevention of asthma attacks is 
disodium cromoglycate (Cromolyn), which has its therapeutic 
effects by stabilizing mast cells, thereby inhibiting the 
release of mediators (Atkins, Norman, & Zweiman, 1978). 
Cromolyn has been shown to be effective in some 
individuals. However, in order to be effective, it must be 
inhaled three or four times daily. In addition, a trial 
period of 8 to 12 weeks is necessary in order to determine 
its effectiveness for an individual (Bernstein, 1985). The 
complexity of this regimen reduces the likelihood of 
adherence to it. Thus, it is used much less frequently 
than the other medications.
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Psychological Factors in Asthma
Despite the availability of several medical treatment 
methods, asthma has continued to be a difficult disease to 
manage. One of the factors complicating the management of 
asthma is the relation between emotions and asthma. As 
early as the twelfth century, the physician Maimonides 
referred to the role of emotions in asthmatic 
symptomatology (Munter, 1968). Because of this, 
psychologists have been actively involved in attempting to 
help manage the disorder by treating the emotional 
components. One of the important emotional complications 
frequently associated with asthma is depression (Thompson & 
Thompson, 1984). This is not unusual, however, because 
depression often is associated with medical illness.
Whereas the incidence of depression in the general 
population is approximately 4.3% (Weissman & Meyers, 1978), 
the incidence of diagnosable depression in medically ill 
patients may be as high as 58% (Nielson & Williams, 1980). 
Although this figure may be artificially high due to the 
fact that depression and medical diseases often have many 
symptoms in common, there is little doubt that having a 
severe illness can result in dysphoria and depressed affect 
(Frerichs, Aneshenesel, Yokopenia, & Clark, 1982).
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In asthma, as in other severe chronic medical 
illnesses, depression is likely linked to the threat of 
death, decreased ability to engage in many of the patient's 
usual activities, and disrupted interpersonal relations 
(Klerman, 1981). Depression among asthmatics may lead to a 
decrease in compliance to medical recommendations and 
decreases the probability of effective medical management 
(Stein, 1981). In addition, depression may lead to 
increased medical utilization and a decrease in the ability 
to effectively cope with stressful situations (Dirks,
Jones, & Kinsman, 1977). Thus, while depression among 
asthmatics may be a problem of its own, it also makes 
effective treatment more difficult.
Anxiety/Stress Theories
Despite the importance of depression in chronic 
illness in general, and with respect to asthma in 
particular, most of the psychological research in asthma 
has focused on anxiety, stress, and classical conditioning 
as major complicating factors. This is largely due to the 
fact that they are hypothesized to play a primary role as 
causative agents in asthma (Erskine-Millis & Schonell,
1981). In addition, it has previously been suggested that 
anxiety frequently accompanies an acute asthma attack 
(Trueting & Ripley, 1948). The hypothesis is that through
classical conditioning processes (i.e. the repeated pairing 
of conditioned and unconditioned stimuli), the anxiety 
accompanying the asthma attack becomes conditioned to the 
asthma attack, and stimuli in the environment at the time 
of the attack may also become conditioned stimuli 
(Turnbull, 1962). The unconditioned stimulus (UCS) in this 
case would be the dust, pollen, or tobacco smoke which 
elicited the initial asthma attack, the unconditioned 
response (UCR). The anxiety and environmental stimuli 
which accompany the attack become conditioned stimuli (CS) 
which become, by virtue of the conditioning process, 
capable of producing an asthma attack (CR). A vicious 
cycle is thereby established where anxiety or the 
conditioned environmental stimuli may produce an asthma 
attack, which can then become conditioned to even more 
environmental stimuli (Franks and Leigh, 1959; Turnbull, 
1962). As the attacks continue to occur in a variety of 
settings, the range of stimuli increases until the 
individual is conditioned to respond to several stimuli 
with an asthma attack (Khan, 1974a, 1974b). Stressors in 
the environment are thought to contribute by increasing the 
state of anxiety as one part of the stress response.
There is a substantial amount of experimental data to 
support the above hypothesis. Laboratory studies have
shown that respiratory changes representing asthmatic 
behavior can be easily conditioned in both animals and man 
(Dekker & Groen, 1956; Gantt, 1944; Liddell, 1951; 
Ottenberg, Stein, Lewis, & Hamilton, 1958) and that 
conditioning can occur in as few as five pairings (Noelpp- 
Eschenhagen & Noelpp, 1954). A hypothesis that these 
changes may be amenable to stimulus generalization and 
higher order conditioning (Turnbull, 1962) has also been 
confirmed with the use of experimental studies (Dekker, 
Pelser, & Groen, 1957; Gantt, 1964; Ottenberg et al., 1958; 
Vaughan, 1939). In addition, clinical research data have 
shown that asthmatics may become conditioned to 
environmental situations (Herxheimer, 1953) and that higher 
order conditioning in man likely involves emotional factors 
(e.g. anxiety; Wolf & Holmes, 1950). Thus, it has been 
established that anxiety and conditioning principles are 
likely to play an important role in the exhibition of 
asthma symptoms.
Psychological Treatment Techniques. Much of the research 
in the area of asthma has focused on classical conditioning 
and anxiety as major complicating factors, and most of the 
current treatment techniques have reflected this emphasis. 
In an effort to treat the conditioning directly, some 
investigators have evaluated a two phase treatment
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technique designed to "countercondition" the asthma 
attacks. During the first phase, the subject is told to 
attempt to decrease airways resistance by a predetermined 
amount during each of three trials. Subject are given 
feedback regarding performance and then is given social 
reward (i.e. praise) for each successful attempt. 
Theoretically, the conditioning aspect is the association 
of decreased airways resistance with the praise. During 
the second phase, a mild bronchoconstriction is induced and 
the subject is instructed to relax and to decrease airways 
resistance until baseline levels are reached. In one 
study, a group treated with the counterconditioning method 
had significant reductions in the amount of medication 
taken, number of emergency room visits, and number of 
asthma attacks when compared to a no-treatment control 
group (Khan, Staerk, & Bonk, 1974). However, attempts to 
replicate these findings have failed (Danker, Miklich, 
Pratt, & Creer, 1975; Khan, 1977).
Other treatment techniques have attempted to directly 
decrease the anxiety that is presumed to be associated with 
asthma attacks. It is hypothesized that this will reduce 
respiratory resistance and thereby reduce the frequency and 
severity of asthma attacks. Relaxation training is the 
most popular method and several studies have attempted to
test its efficacy (Alexander, 1972; Alexander, Cropp, & 
Chai, 1979; Alexander, Miklich, & Hershkoff, 1972; Erskine 
& Schonell, 1979; Erskine-Millis & Schonell, 1981; Phillip, 
Wilde, & Day, 1972). One of the first studies utilizing 
this technique showed that children in a relaxation treated 
group evidenced increases in pulmonary functioning measures 
whereas those in a no-treatment control group did not 
(Alexander, 1972). However, the pulmonary measures used 
were effort-dependent (highly dependent upon the patient's 
physical effort) and may not have accurately reflected true 
pulmonary functioning of the asthmatics due to variance 
contributed by patient expectation and/or patient 
cooperation. A later study (Alexander, Cropp, & Chai,
1979) revealed that although relaxation was again shown to 
produce changes in effort-dependent measures of pulmonary 
functioning, there were no changes evidenced in effort 
independent measures (measures independent of the patients' 
physical effort). Thus, the efficacy of progressive 
muscular relaxation remains questionable.
Relaxation assisted by EMG biofeedback has also been 
tested in several studies. One study showed that an EMG 
biofeedback group showed significant changes in pulmonary 
functioning when compared to a group receiving Jacobsonian 
relaxation and a no-treatment, control group (Davis,
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Saunders, Creer, & Chai, 1973). However, they found it to 
be effective for only those asthmatics not receiving 
steroid medications. A later study supported the 
effectiveness of biofeedback by showing that an EMG 
biofeedback treated group produced significantly greater 
therapeutic differences than either a no-treatment control 
group or a group receiving false feedback (Kotses, Glaus, 
Crawford, Edwards, & Scherr, 1976). Other studies have 
also reported significant therapeutic effects attributed to 
biofeedback (Kotses, Glaus, Bricel, Edwards, & Crawford, 
1978). However, despite the consistency of positive 
results, biofeedback treatments have produced relatively 
little change in the pulmonary functioning of the treated 
patients. Biofeedback treatments have resulted in 
increases in pulmonary function of only 3% whereas it is 
generally recognized that changes of 15% are necessary for 
any clinically meaningful results to be produced (Keeffe, 
1984). Therefore, the clinical efficacy of biofeedback 
remains questionable.
Systematic desensitization methods have produced 
conflicting results. In an initial study utilizing these 
methods, desensitization increased pulmonary functioning 
significantly greater than did either a relaxation group or 
a group that received relaxation plus the suggestion that
1 5
they would improve in certain specific ways (i.e. increased 
pulmonary functioning, decreased respiratory problems; 
Moore, 1965). However, there were no differences between 
the groups on the self-reported number of asthma attacks.
A later study (Yorkston, McHugh, Brady, Serber, & Sergeant, 
1974) confirmed the superiority of desensitization by 
showing that pulmonary functioning significantly increased 
and medication usage significantly decreased for the 
desensitization group as compared to a group treated with 
relaxation. However, there were no changes on the 
patients' ratings of their symptoms. Additionally, 
although both groups improved on subjective ratings by both 
therapists and patients, there were no significant 
differences between the groups. A follow-up study showed 
that asthmatics given steroids benefited from 
desensitization whereas those not given steroids received 
no therapeutic benefit (Yorkston, Eckert, McHugh,
Philander, & Blumenthal, 1979). Thus, several studies have 
indicated the potential benefits of desensitization. 
However, the efficacy of this procedure has not gone 
unquestioned. In fact, one study found that controls rated 
their symptom frequency as more improved than did members 
of a desensitization group (Miklich, Renne, Creer, 
Alexander, Chai, Davis, Hoffman, & Danker-Brown, 1977).
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This was found both during treatment and at a 10-week 
followup. Therefore, the overall evidence on the 
effectiveness of desensitization is inconclusive.
Assessment Studies. Despite the relatively large number of 
treatment studies and treatment techniques within the 
psychological literature, relatively few assessment studies 
have tested the theoretical hypotheses. The studies that 
have been conducted yielded inconsistent results. Of most 
theoretical importance are the studies that have attempted 
to assess the role of anxiety and stress in asthma. This 
is because the prevailing psychological theory is that 
stress and/or anxiety can initiate or exacerbate an asthma 
attack. However, research studies designed to test this 
theory have reported conflicting results.
Results from studies using several different 
techniques have shown that some asthmatics are more anxious 
than nonasthmatics. Studies supporting this position have 
utilized observer rating scales (Rees, 1956), neuroticism 
scales,(Dekker, Barendregy, & De Vries, 1961), and 
psychiatric interviews (Teiramaa, 1978). However, several 
other studies have found no differences between asthmatics 
and a normal control group (c.f., Franks & Leigh, 1956; 
Rosenthal, Aitken, & Zealley, 1973) on measures of anxiety. 
Within the stress literature, most of the studies have
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consistently indicated that emotions and life stresses can 
affect the severity of asthma symptoms. This has been 
indicated both in laboratory studies (Aitken, Zealley, & 
Rosenthal, 1969; Miklich, Rewey, Weiss, & Kolton, 1973), 
and in studies which have used measures of major life 
events (Araujo, Arsdell, Holmes, & Dudley, 1973). However, 
a recent study utilizing a clinical interview, a rating 
form completed by the interviewer (the Brief Psychiatric 
Rating Scale), and a self-report inventory (the Edwards 
Personal Preference Schedule) has offered evidence 
contradictory to this (Spittle & Sears, 1984).
Additionally, another study found that although the number 
of life stresses (as measured by a checklist of current 
problems) was related to self-reported measures of asthma 
symptoms, traditional medical measures of asthma severity 
(i.e. physician ratings, pulmonary function tests) were not 
associated with the amount of stress (Plutchik, Williams, 
Jerrett, Karasu, & Kane, 1978). Thus, the relation between 
anxiety and asthma has remained extremely controversial, 
and although most studies agree that there is a significant 
positive relation between stress and asthma, some studies 
have found contradictory evidence.
There are two major problems with most all of the 
studies which have attempted to assess the relation of
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stress or anxiety with asthma. First, most of the anxiety 
studies measure a "trait" anxiety and relate that to the 
severity of an individual's asthma. Second, the stress 
studies have typically measured the major life events that 
have occurred in the past six months or one year of each 
individual's life and related this to their asthma 
severity. The problem with this approach is that asthma 
symptoms do not remain stable within an individual (and 
thus would not be expected to consistently be related to 
any trait measure) nor do they vary only six months or one 
year at a time. Asthma symptoms vary on a day-to-day 
basis. Thus, if one is to establish a relational pattern 
between stress or anxiety and asthma symptom severity, 
these variables would have to be measured repeatedly and 
concurrently.
Two recent studies recognized this problem and 
attempted to address these concerns. The first study 
(Goreczny, Brantley, Buss, & Waters, 1988) measured six 
signs and symptoms of asthma severity via self-monitoring 
techniques. These six variables included the quality of 
sleep, amount of wheezing, amount of coughing, interference 
with daily routine, amount of activity restriction, and a 
subjective rating of overall discomfort. In addition, 
daily measures of stress and anxiety were collected using
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self-report inventories designed for this purpose. Results 
of this study indicated that four of the six variables (all 
but quality of sleep and overall discomfort) were 
significantly related to daily levels of stress. High 
stress days were associated with greater symptom severity. 
However, asthma symptom severity was not significantly 
different between days of high anxiety and days of low 
anxiety. Results from the anxiety analyses did approach 
significance though, and there was noted to be a great deal 
of individual variability.
One of the shortcomings of this study was its reliance 
on self-report to measure symptom severity. A recent study 
(Nathan, Brantley, Goreczny, & Jones, 1988) corrected this 
deficit by using both self-reported asthma symptoms as well 
as objective measures of daily pulmonary functioning. In 
addition, daily stress and anxiety were measured. Results 
of this study confirmed the relation between stress and 
increased asthma severity based upon self-report measures. 
However, objective measures of pulmonary functioning were 
not related to the amount of stress. Other results of this 
study suggest that anxiety is related to asthma symptom 
severity, though the relation is not as strong as that 
between stress and asthma.
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Both studies are consistent with many previous studies 
in that they supported the theory that stress and asthma 
symptom severity are associated. However, as previously 
noted, although the majority of studies support this 
theory, some important inconsistencies have emerged. One 
of the most commonly reported inconsistencies is the degree 
to which asthmatics may respond to stressful or emotional 
stimuli. The heterogeneity of asthmatics and the 
realization that there may be subgroups of asthmatics who 
have stress precipitated attacks versus those who do not 
has long been recognized (Rackemann, 1928). However, the 
differences between these groups along various dimensions 
is an area that has received relatively little empirically 
validated research. This is surprising considering the 
relatively large number of studies that have compiled 
sufficient data to indicate that asthmatics do not 
uniformly respond to stress in the same manner (Kinsman, 
Dirks, Jones, & Dahlem, 1980).
Laboratory studies employing the threat of inducing an 
asthma attack as the stressor have consistently shown that 
while some asthmatics respond to the stressor with 
increased breathing difficulties, many others do not 
(Luparello, Leist, Lourie, & Sweet, 1970; Luparello, Lyons, 
Bleecker, & McFadden, 1968; Luparello, McFadden, Lyons, &
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Bleecker, 1971; McFadden, Luparello, Lyons, & Bleecker, 
1969). This may be due to the fact that there is a 
tendency for individual subjects to respond to sensory 
stimulation in only one physiological modality, a concept 
called response stereotypy (Lacey, Bateman, & Van Lehn, 
1953; Lacey & Lacey, 1958). For instance, one subject 
might respond to stimuli with an increase in airways 
resistance while another might respond with an increase in 
heart rate. The laboratory results on asthmatics cited 
above have been validated by investigators from different 
research laboratories (c.f., Phillip, Wilde, & Day, 1972; 
Spector, Luparello, Kopetsky, Souhrada, & Kinsman, 1976; 
Strupp, Levenson, Manuck, Snell, Hinrichsen, & Boyd, 1974). 
Depending upon the study and laboratory cited, the number 
of stress responders ranges from one-third to two-thirds of 
the study sample (Kinsman et al., 1980).
Utilizing methods other than the laboratory studies 
described above, additional studies have also shown that 
although some asthmatics should be classified as stress 
responders, another group appears to be unaffected by 
stress. For example, 20% of asthmatics responded 
positively to a hypnotic suggestion that they would 
experience an episode of bronchospasm (Khan, Staerk, &
Bonk, 1974) and approximately 45% of subjects acknowledged
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in interviews that stress/emotions have in the past 
precipitated some of their asthma attacks (Aitken, Zealley, 
& Rosenthal, 1969; Kahn, Staerk, & Bonk, 1974). 
Additionally, one study showed that different subgroups of 
subjects who received approximately the same scores on a 
major life events scale (one measure of stress) differed 
significantly with respect to the severity of their asthma 
symptoms (Araujo, Arsdel, Holmes, & Dudley, 1973). Thus, 
these studies provide an extensive amount of evidence to 
indicate that asthmatics differ in their susceptibility to 
stress mediated asthma attacks. In addition to explaining 
the inconsistencies in the assessment studies, this may 
help to explain the inconsistent and generally poor results 
obtained from treatment studies which employ anxiety 
reduction or stress management programs. Although these 
programs may have helped to alleviate problems for some of 
the asthmatics, the results of the studies may be obscured 
by the inclusion of subjects who do not benefit from the 
program.
A second inconsistency within the stress/asthma 
literature is the divergence of measurements of asthma 
severity using self-report of the patients and those using 
standard medical tests. The reason for this divergence is 
unclear, but it has been validated by different groups of
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investigators (Nathan, Brantley, Goreczny, & Jones, 1988; 
Purcel et al., 1978) and is in agreement with the vast 
majority of previous research. Self-report of asthma 
symptomatology is consistently related to measures of 
stress. Studies assessing the relation between traditional 
medical measures of asthma severity and stress have 
reported inconsistent results, largely due to the 
instability of the medical measures (Burrows, 1979). Thus, 
self-report measures of asthma related problems take on an 
important role as one of the primary assessment 
instruments.
Illness Related Cognitions
One very important aspect of illness symptomatology often 
overlooked is the patient's self-report of their attitudes 
and cognitions towards illness. Until recently, these 
variables have received relatively little attention in the 
research literature. However, the small amount of existing 
data does indicate that cognitive factors are likely to 
influence health and illness in several ways. First, 
cognitive stimuli are able to elicit physiological changes 
that mimic or reproduce the pathological changes associated 
with specific disease states (Dekker & Groen, 1956; Wolf & 
Goodell, 1968). For example, in one study (Dekker & Groen, 
1956), asthmatics were asked to visualize situations that
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had produced asthmatic attacks in the past. This cognitive 
process of visualization was able to produce full-blown 
asthma attacks in the laboratory setting without exposure 
to any allergens.
Second, there is a considerable amount of evidence 
that patients' reports about their attitudes toward their 
illness play a substantial role in the severity of their 
illness and are significantly related to treatment outcome 
measures (Smith & Apfeldorf, 1975; Turk, 1979). Cognitive 
coping strategies among myocardial infarction patients have 
been shown to be related to the degree of disability 
experienced (Klein, Dean, & Willson, 1965) as well as their 
chances of survival (Pranulis, 1975; Klein, 1975). A 
similar relation has been shown to exist for surgery 
patients (Cohen & Lazarus, 1973).
Finally, the course of action an individual takes 
regarding his/her health is not dependent upon the presence 
of specific symptoms, but rather upon the patient's 
appraisal and interpretation of those symptoms 
(Meichenbaum, 1977; Rodin, 1978). It has been estimated 
that as many as 70% of all myocardial infarction patients 
misinterpret or deny the source of their symptoms (Gentry, 
1975). Denial was also found to be a common way women 
coped with the discovery of breast lumps that signaled the
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possibility of breast cancer (Katz, Weiner, Gallagher, & 
Heilman, 1970). The importance of this cognitive appraisal 
should not be underestimated. A delay in seeking medical 
advice can have disastrous consequences (e.g., metastasis 
of cancer to other body parts, an increased amount of 
affected heart tissue in a heart attack). Therefore, an 
individual's interpretation of physical symptoms and 
his/her attitudes toward illness may affect behavior and 
subsequent health.
Despite the presumed importance of cognitive factors 
in bronchial asthma (Dekker & Groen, 1956; Munter, 1968), 
very little known about these factors and how they relate 
to asthmatic functioning. Primarily, this is because until 
recently, no measurement instrument existed that could 
assess the cognitive functioning of asthmatic patients in a 
reliable and valid manner. In order to address this 
problem, a group of investigators designed two self-report 
instruments: the Asthma Symptom Checklist (ASC) and the 
Respiratory Illness Opinion Survey (RIOS).
The Respiratory Illness Opinion Survey (RIOS) measures 
certain specific attitudes that asthma patients may have 
regarding their illness (e.g. optimism about successful 
management of the illness, attitudes and expectations about 
their role and the role of medical staff in their
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treatment). One hundred nine statements regarding 
respiratory illness, health care, and hospitalization (e.g. 
"My health is in the hands of others.") were developed and 
selected by four psychologists involved in the treatment of 
asthma. These statements were then administered to a group 
of asthmatics and subjected to item analysis and cluster 
analysis. Statements judged to be inadequate by the item 
analysis (e.g. poor test-retest reliability, limited 
response range) or failed to add significantly to the 
cluster solution were dropped, leaving 36 statements 
defining five primary attitudinal clusters: Optimism, 
Negative Staff Regard, Specific Internal Awareness (of 
their body functioning), External Control, and 
Psychological Stigma (associated with asthma). The scale 
has been shown to possess adequate reliability and validity 
(Kinsman, Jones, Matus, & Schum, 1976) and subscale scores 
accurately predict medical and therapeutic outcomes 
(Staudenmayer, Kinsman, & Jones, 1978). For example, 
patients with low scores on subscales Negative Staff 
Regard, External Control, and Psychological Stigma tended 
to be given a more intense drug regimen upon discharge from 
the hospital. On the other hand, those with low Optimism 
scores were more likely to judge their illness as being 
severe and creating substantial interference in their
27
normal daily routine. They were also more likely to be 
rehospitalized. Similar results have been obtained in a 
cross cultural study with Dutch asthmatics (Kaptein, 1982).
The Asthma Symptom Checklist (ASC) is composed of a 
list of 50 symptoms that may occur during an asthma attack. 
Initial selection of symptoms was based on interviews with 
asthmatic patients who were asked to describe their 
symptomatology during an asthma attack. The original list 
of 77 symptoms was given to a group of asthmatics who rated 
the frequency of occurrence of each symptom. Those data 
were then subjected to item analysis and cluster analysis. 
Items that did not load on any of the identified clusters 
were discarded. The final checklist of symptoms has been 
shown to have adequate reliability and validity (Kinsman, 
Luparello, O'Banion, & Spector, 1973; Kinsman, Spector, 
Shucard, & Luparello, 1974) and consists of five clusters: 
panic-fear, irritability, fatigue, bronchoconstriction, and 
hyperventilation-hypocapnia.
One of the five subscales (i.e., panic-fear) has 
consistently been shown to be related to functional 
measures of impairment among asthmatics. It is related to 
the intensity of drug treatment two to six months after 
discharge from the hospital (Kinsman et al., 1977), patient 
initiated requests for as-needed (PRN) respiratory
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medications (Dahlem, Kinsman, & horton, 1977), and rates of 
rehospitalization (Staudenmayer, et al., 1979). The panic- 
fear scale is hypothesized to be a measure of anxiety. 
However, rather than reflecting a degree of general 
anxiety, the ASC panic-fear scale measures the amount of 
illness- specific anxiety. It is used as an aid to help 
assess the degree of panic associated with asthma attacks 
and is only minimally related to characterological or trait 
anxiety (Pearson product-moment r = 0.34) as measured by 
the Taylor Manifest Anxiety Scale (Kinsman, Dirks, Dahlem,
& Heller, 1980).
The ASC and RIOS have been combined with the Minnesota 
Multiphasic Personality Inventory (MMPI; a measure 
frequently used to assess emotional and psychological 
factors in chronic illness populations) in several 
assessment studies. This combination has been shown to be 
effective in predicting rehospitalization rates of 
asthmatics with correct predictions ranging from 70% to 84% 
(Dirks, 1982; Dirks & Kinsman, 1981). Also, patients with 
different patterns of compliance/noncompliance to as needed 
(PRN) medications have been shown to produce different 
patterns of scores on these three measures (Kinsman, Dirks, 
& Dahlem, 1980). Thus, the ASC and RIOS have provided a
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significant amount of data that attest to their usefulness 
as valid indicators of asthmatic functioning.
Purpose of this Study
The issue of stress reactivity and its measurement has 
become a major area of research in the past few years. In 
fact, recently the United States Department of Health and 
Human Services was involved in the sponsorship of a 
conference devoted solely to stress, stress reactivity, and 
implications for cardiovascular disease (Weiss, Mathews, 
Detre, & Graeff, 1984). However, there have been no 
studies which address the issue of stress reactivity and 
stress responders among asthmatics. Given the evidence 
that stress is associated with the severity of asthma 
attacks (Goreczny, Brantley, Buss, & Waters, 1988; Nathan, 
Brantley, Goreczny, & Jones, 1988), this issue becomes even 
more important. Not only is it important to differentiate 
stress responders from nonresponders for theoretical 
reasons, but also for the implementation of successful 
treatment techniques. Thus, the successful and efficient 
identification of stress responders and the elucidation of 
ways in which stress responders and stress nonresponders 
differ may be important for improving therapy.
The suggestion that stress level is associated with 
asthma attack severity has received continued support. It
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was not until recently however, that this association was 
clearly established (Goreczny, Brantley, Buss, & Waters, 
1988). Additionally, it appears, as would be expected, 
that the effects of stress vary from individual to 
individual. The notion of individual differences between 
asthmatics in response to stress has previously been 
addressed (c.f., Kinsman et al., 1980), but this area is 
insufficiently researched. In addition, although stress 
may have several different effects involving changes in 
disease severity, in self-report of affective changes, and 
in self-report of cognitive alterations (Bradley & Prokop, 
1982; Burish, 1981), these effects are not well delineated.
Given the association of stress with asthma severity, 
it is also possible that those individuals who have stress 
associated asthma attacks also have changes in the areas 
noted above. However, the differences within an illness 
population between stress responders and stress 
nonresponders have never been adequately studied. The 
elucidation of these differences may aid in a more 
comprehensive understanding of the relation between stress 
and illness, may provide information and a rationale to 
account for differences in stress responsiveness, and may 
suggest appropriate interventions to aid in the treatment 
of stress related asthma attacks. The purpose of the
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present study was to assess if there are any differences in 
affective/emotional functioning, asthma related 
symptomatology, or cognitions about their illness between 
asthmatics with stress related symptomatology and those 
with asthma which is unresponsive to stress.
Given what is known about the interaction of stress 
with asthma, the following hypotheses were asserted:
1) Several studies have shown that asthmatics differ 
in the degree to which they respond to stress (c.f., 
Spector, et al., 1976). Although no one has yet 
proposed an adequate way of classifying individuals 
into stress responder versus stress nonresponder 
groups, there is a significant amount of data to 
indicate that such a grouping is warranted (c.f.,
Khan, et al., 1974). In addition, recent research has 
demonstrated that self-monitoring of the clinical 
asthma symptomatology appears to be responsive to 
changes in the amount of daily life stressors 
(Goreczny et al, in press; Nathan et al., 1988). 
Therefore, it was hypothesized that asthmatics would 
be able to be identified as stress responders or 
stress nonresponders on the basis of self-monitoring 
of their asthma symptomatology.
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It was also hypothesized that stress responders and stress 
nonresponders would differ in a variety of ways:
2) Affective/emotional functioning. The occurrence 
of daily stressors is extremely unpredictable and 
therefore uncontrollable. It has been shown that the 
unpredictable stressors have the more adverse effects 
upon an individual's functioning (Glass, Singer, & 
Friedman, 1969). Part of the reason for this may be 
the unexpectable nature of the stressor. This often 
leads to emotional responding (Glass, Heim, & Singer, 
1971) and may thus account for the negative emotional 
states produced by stress (Braun & Linder, 1979;
Stoyva & Anderson, 1982). Therefore, it was 
hypothesized that those individuals who have stress 
mediated asthma attacks would evidence more emotional 
distress (i.e., depression, anxiety) than those who do 
not have stress mediated asthma attacks.
3) Disease specific problems. It has been clearly 
shown that at least for some asthmatics, stress level 
and asthma severity are related (c.f., Goreczny, et 
al., 1988; Purcel, et al., 1978). The direction of 
causation can be bidirectional. It has been shown 
that laboratory stressors can result in an asthma 
attack (c.f., Luparello, et al., 1970). However, it
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is just as possible that having an asthma attack can 
result in additional environmental stressors (e.g. 
wheezing and coughing creating problems completing a 
task). Because of this and the ubiquity of stress in 
everyday living, it is likely that asthmatics who are 
stress responders have the more severe asthma attacks. 
The stress responders are more likely to have 
increased respiratory difficulties during the periods 
of stress than the nonresponders and thus present with 
an increased number of asthma attacks. The increased 
likelihood of an asthma attack makes it more likely 
that a conditioning process will exacerbate the 
situation, leading to potentially more respiratory 
difficulty (Franks & Leigh, 1959). Therefore, it was 
hypothesized that the stress reactors would show the 
more severe asthma specific symptomatology.
4) Associated cognitions regarding asthma. It is 
known that when people are stressed, they may 
experience negative cognitions (Burish, 1981).
However, the effects of chronic stress reactivity upon 
asthmatics and the cognitive components (i.e., 
attitudes) related specifically to their disease has 
never been investigated. What has been established 
however, is the association of depression and negative
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cognitions (Sacco & Beck, 1985). Because it was 
hypothesized that depression would be greater in 
stress responders than in nonresponders (see 
Hypothesis 1) and it is known that depression is 
associated with an increased amount of negative 
cognitions, it was also hypothesized that stress 
responders would be significantly more negative in 
their attitudes and cognitions than the stress 
nonresponders.
As stated earlier, the major psychological hypothesis in 
asthma research concerns the role of anxiety. Although 
there has been considerable debate over the importance of 
characterological or trait anxiety, illness-specific 
anxiety (i.e., anxiety related directly to the fear of an 
asthma attack and its consequences) has consistently been 
identified as a major complicating factor in medical 
management and as a predictor of medical outcome. Thus, 
several hypotheses related specifically to panic-fear may 
help to elucidate the proposed relation to asthma:
5) Because it is possible that the panic-fear scale 
of the ASC, being a measure of anxiety, is related to 
stress, it was also hypothesized that scores on the 
panic-fear subscale would account for a large 
proportion of variance in stress related
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symptomatology. It was also hypothesized however, 
that other measures of affective/emotional responding 
(i.e., depression and anxiety) would add significantly 
to the amount of variance which could be predicted.
6) Because panic, fear, stress, and anxiety are often 
confused (Endler & Edwards, 1982; Speilberger, 1976), 
it is possible that the panic-fear scale represents 
one way of distinguishing stress responders from 
stress nonresponders. Given the difficulty in 
discerning between the different concepts listed above 
and their presumed, though unclear, relation to each 
other (Endler & Edwards, 1982), it was hypothesized 
that panic-fear would be able to significantly 
discriminate between stress responders and stress 
nonresponders. It was further hypothesized that MMPI- 
D and MMPI-Pt would add to the discriminatory power.
Method 
Subjects.
Subjects included 15 stress responder asthmatics and 
19 stress nonresponder asthmatic patients from Earl K. Long 
Memorial Hospital. Only adult subjects over age 18 were 
recruited for participation in this study. Patients were 
recruited from ongoing referrals to the Pulmonary 
Rehabilitation Program. Patients are referred to this
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program by physicians and staff within the hospital. In 
order to participate in the program, subjects were required 
to be diagnosed by one of the hospital physicians as having 
asthma. Diagnosis was made based upon chest x-rays, 
history of complaints, pulmonary function tests, and 
physical examination. Upon admission to the Pulmonary 
Rehabilitation Program, referrals were evaluated as to 
their appropriateness for either the stress responder or 
stress nonresponder group (see Statistical Analysis 
section). Consecutive referrals were evaluated until at 
least 15 subjects per group met the qualifications for 
inclusion.
Instruments.
Daily Stress Inventory (DSI). This is a 58 item self- 
report inventory designed to measure the number and 
perceived impact of daaly stressors (see Appendix A). 
Individuals first rate the occurrence/nonoccurrence of each 
item. Then, on those items which did occur, the 
individuals rate the amount of impact they feel that it had 
on them. The perceived impact is rated on a Likert scale 
ranging from 1 (occurred but was not stressful) to 7 
(caused me to panic). In between these extremes are 
gradations of severity. Two scores are then calculated: a) 
Frequency, which is simply a count of the number of items
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that were reported to have occurred during the 24 hour 
period, and 2) Sum, which is equal to the total of the 
item-impact ratings. The DSI has been shown to have 
adequate reliability and validity (Brantley, Cocke, Jones,
& Goreczny, 1988; Brantley, Waggoner, Jones, & Rappaport, 
1985) and scores on the DSI are correlated with daily 
cortisol levels (Brantley, Dietz, Tulley, & Jones, 1988). 
Self-Monitoring. Previous research has shown that several 
asthma symptoms, when self-monitored, appear to be 
responsive to stress (Goreczny, Brantley, Buss, & Waters, 
1988). These symptoms include amount of wheezing, amount 
of coughing, interference with daily routine, and number of 
activities interrupted due to respiratory problems. A 
subsequent study confirmed the susceptibility of these 
symptoms to the amount of perceived stress (Nathan, et al., 
1988). Therefore, subjects will be asked to monitor these 
four symptoms on a daily basis for 21 days (see Appendix 
B). Previous data on self-monitoring techniques have shown 
this to be a reliable method of measurement and for 
gathering data on physical signs and symptoms(Roskies,
1979; Taylor, Zlutnick, Corley, & Flora, 1980).
Asthma Symptom Checklist (ASC). This is a 36 item 
checklist consisting of a list of symptoms that are rated 
on a 5 point scale of frequency of occurrence (1 = never
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and 5 = always). The signs and symptoms on the checklist 
make up 5 symptom clusters. These include panic-fear, 
irritability, fatigue, hyperventilation-hypocapnia, and 
bronchoconstriction. The scale and the clusters have been 
shown to have adequate reliability and validity (Kinsman, 
Luparello, O'Banion, Spector, 1973). Internal consistency 
coefficients for the five clusters are 0.93, 0.90, 0.85, 
0.83, and 0.83, respectively. Test-retest reliability 
coefficients are 0.95, 0.86, 0.76, 0.78, and 0.82 for the 
five respective clusters. A later study replicated the 
results of the initial five cluster solution (Kinsman, 
Dahlem, Spector, & Staudenmeyer, 1977). The use of this 
scale represents an acceptable way to measure the severity 
of asthma symptomatology because it is more stable than 
pulmonary function tests, which can vary widely from one 
reading to the next, and scores on this scale represent an 
accurate way of predicting long term functioning (see 
Appendix C ).
Respiratory Illness Opinion Survey (RIOS). The RIOS is a 
questionnaire consisting of 36 statements regarding 
attitudes toward respiratory illness and its treatment (see 
Appendix D). Each statement is rated on a five point scale 
(1 = strongly agree and 5 = strongly disagree). A cluster 
analysis identified 5 attitude categories which were
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subsequently labeled Optimism, Negative Staff Regard, 
Specific Internal Awareness, External Control, and 
Psychological Stigma. This scale has been shown to have 
adequate reliability and validity (Kinsman, Jones, Matus, & 
Schum, 1976) and is frequently used in comprehensive 
assessments of asthmatics. Internal consistency 
coefficients for each of the subscales are: Optimism (.80), 
Negative Staff Regard (.84), Specific Internal Awareness 
(.68), External Control (.76), and Psychological Stigma 
(.82 ).
Minnesota Multiphasic Personality Inventory (MMPI). The
MMPI is a widely used instrument useful in the assessment 
of emotional and psychological factors. It produces a 
profile consisting of 3 validity scales and 10 clinical 
scales. It has been widely used to assess the 
psychological factors associated with a variety of physical 
disorders including chronic pain (Armentrout, Moore,
Parker, Hewett, and Feltz, 1982) and headache (Rappaport, 
McAnulty* Waggoner, & Brantley, 1987).
Procedure.
Subjects attended four weekly sessions. During the 
first session, the project was explained and the subjects 
were required to sign an informed consent form (see 
Appendix E) before being permitted to continue. They were
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then trained to properly complete the Daily Stress 
Inventory (DSI) and self-monitoring forms on which they 
recorded daily amounts of wheezing, coughing, activity 
restriction, and interference with daily routine. At the 
second session, monitoring forms from the previous week 
were collected, any questions regarding the monitoring were 
answered, and new forms for the following week were 
distributed. The subjects were then instructed to complete 
the Minnesota Multiphasic Personality Inventory (MMPI).
At the third session, monitoring forms were collected, 
questions regarding these forms were answered, and new 
forms were distributed. Subjects were then instructed to 
complete the Asthma Symptom Checklist (ASC) and the 
Respiratory Illness Opinion Survey (RIOS). At the fourth 
and final assessment session, all subjects returned the 
monitoring forms from the third week of monitoring. Any 
other questions regarding the program were answered at this 
time and the subjects were instructed to call back in 
approximately 3 weeks if they wish to obtain feedback on 
the information they provided.
Results
The initial sample consisted of 42 asthma subjects. 
Because we can study the effects of stress on illness 
symptomatology only when there are active signs of the
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illness, any subject who reported no problems with asthma 
symptomatology during the study period was excluded. In 
addition, an outlier analysis was performed. Any subject 
who scored more than or less than three standard deviations 
from the mean on any of the four asthma symptom variables 
was excluded (Tabachnick & Fidell, 1983). Three subjects 
from the original 42 were identified and eliminated from 
all further analyses. The means and standard deviations 
for all variables for the remaining 39 subjects are shown 
in Table 1. An intercorrelation matrix consisting of these 
variables is shown in Tables 2, 3 and 4. In order to 
assess the stress responder status of each asthmatic (i.e., 
responder versus nonresponder), a correlation matrix 
consisting of the data from the daily monitoring forms was 
computed for each subject individually. The DSI-frequency 
score was correlated with each of the 4 asthma symptoms 
(i.e., wheezing, coughing, activity restriction, and 
interference with daily routine.) A stress responder was 
defined as someone having at least two significant 
correlation coefficients while a stress nonresponder was 
defined as someone having no significant correlations. 
Although it was initially planned to require 3 significant 
correlations, the asthma symptoms did not covary enough to 
permit this. It was found that only five of the 39
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subjects met this criterion. Thus, this criterion was 
considered overly stringent and was reduced to two 
significant correlations. This new criterion allows for 
acceptance of a more representative sample while still 
helping to prevent the inclusion of subjects with spurious 
results. Utilizing this criterion, 15 subjects were 
identified as stress responders (see Table 1) and 19 
subjects as stress nonresponders (see Table 2). Five 
subjects had one significant correlation from among the 
four (see Table 3). These five subjects were excluded from 
further analyses which involved group membership.
A one-way multivariate analysis of covariance 
(MANCOVA) was performed to look at differences in 
emotional/affective functioning between the two groups 
after controlling for the average number of stressors. The 
one factor was group membership (i.e., stress responder 
versus stress nonresponder), the dependent variables were 
the depression and psychasthenia scores from the MMPI, and 
the covariate was the average DSI-frequency score. The 
results from this analysis (see Table 4) indicated that the 
multivariate effect for group membership was 
nonsignificant, F (2, 29) = 0.34, £ > .10. The 
corresponding univariate ANCOVAs were also nonsignificant.
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This was the case for both MMPI-D, F (2, 30) = 0.15, £ >
.10 and MMPI-Pt, F (2, 30) = 0.37, £ > .10.
The next analysis was designed to look at differences 
between the two groups in terms of their symptomatology, 
number of reported stressors, and score on the ASC panic- 
fear sclae. A one-way MANOVA was calculated with group 
membership constituting the one factor. Six variables 
measuring clinical symptomatology served as the dependent 
variables. These six variables included the panic-fear 
scale from the ASC, the average number of daily stressors 
(as measured by the DSI and averaged over the 21 days), and 
the average severity rating for each of the four monitored 
respiratory symptoms (i.e., wheezing, coughing, 
interference with daily routine, and amount of activity 
restriction). The results of the analysis is shown in 
Table 5. The overall group effect for these six variables 
was nonsignificant, multivariate F (6, 27) = 2.22, £ > .05. 
Five of the subsequent univariate ANOVAs were also 
nonsignificant. This was the case for amount of wheezing,
F (1, 32) = 1.78, £ > .10, amount of activity restriction,
F (1, 32) = 1.82, £ > .10, amount of coughing, F (1, 32) = 
0.58, £ > .10, interference with daily routine, F (1, 32) = 
3.87, £ > .05, and number of daily stressors, F (1, 32) = 
0.92, £ > .10. However, the univariate ANOVA for the ASC
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panic-fear scale was significant, F (1, 32) = 7.13, £ <
.02. Stress nonresponders had significantly higher panic- 
fear scores than stress responders.
In order to look at differences between the groups on 
cognitive components of the disease, a multivariate 
analysis of variance (MANOVA) was performed using the five 
subscales from the RIOS as the dependent measures. Results 
from the MANOVA (see Table 6) revealed a nonsignificant 
effect of group membership, F (5, 28) = 1.09, £ > .10.
Four of the five subscales had corresponding nonsignificant 
effects for group membership. These four scales were 
optimism, F (1, 32) = 0.01, £ > .10, negative staff regard, 
F (1, 32) = 0.27, £ > .10, specific internal awareness, F 
(1, 32) = 0.09, £ > .10, and psychological stigma, F (1,
32) = 0.52, £ > .10. However, there was a significant 
group effect on the scale measuring external control, F (1, 
32) = 5.17, £ < .03. Stress responders had significantly 
higher scores on this scale than did stress nonresponders.
Regression analyses were performed in order to 
ascertain the proportion of variance in stress reactivity 
for each of the four asthma symptoms that could be 
accounted for by panic-fear alone and by a combination of 
panic-fear, depression, and anxiety. Two sets of four 
stepwise regression equations were calculated. The data
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for each of the dependent variables for the seven days on 
which DSI frequency score was highest were added together 
to obtain a high stress score for each variable. The same 
procedure was used to obtain scores for low stress days.
The low stress score for each variable was subtracted from 
the high stress score for that variable. The resulting 
four scores served as the dependent variables for the four 
separate regression analyses. The first set of regression 
analyses included only panic-fear as the independent 
variable. The results of these analyses are listed in 
Table 7. There were no significant effects on any of the 
four equations and the amount of variance accounted for in 
each of the four variables was negligible, ranging from 
.25% (wheezing) to 6.2% (interference with daily routine.) 
The second set of regression analyses include panic-fear, 
MMPI-D, and MMPI-Pt. The results of these analyses are 
listed in Table 8. Again, none of the regression equations 
were significant at the .05 level. However, the regression 
equation on activity restriction approached significance, F 
(3, 35) = 2.85, £ = .051 and accounted for 19.6% of the 
variance.
Finally, two discriminant analyses were performed in 
order to ascertain the ability of the panic-fear subscale 
to distinguish between stress responders and stress
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nonresponders. In the first analysis, the only predictor 
used was the score on the panic-fear subscale. In order to 
reduce bias in the classification rates, a jackknifed 
classification was utilized. The results of this analysis 
are shown in Table 9. The panic-fear subscale was able to 
correctly classify only 58.8% of the subjects. The second 
discriminant function computed utilized three predictors: 
panic-fear, MMPI-D, and MMPI-Pt. A jackknifed 
classification was used here also. These results are 
presented in Table 10. Only 61.8% were correctly 
classified.
Discussion
The purpose of this study was to attempt to 
distinguish between stress responder asthmatics and stress 
nonresponder asthmatics and to assess their differential 
functioning across several levels. Given the recent 
research showing that asthma symptomatology monitored on a 
daily basis is related to the number of daily stressful 
life events (Goreczny, et al., 1988; Nathan, et al., 1988), 
the present paper attempted to distinguish between stress 
responders and stress nonresponders on the basis of a 
demonstrated relation between life events and respiratory 
symptoms. In the present investigation, it was found to be 
possible, using correlational procedures, to distinguish
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between two groups of asthmatics: one group whose asthma 
symptomatology had no relation to the number of daily 
stressors and a second group who did evidence a stress- 
asthma symptom relation. However, results of this paper 
failed to demonstrate that the two groups differ on the 
dimensions measured, thereby questioning the significance 
of this distinction. This is consistent with previous 
research literature. Although there is a good rationale to 
expect there to be subgroups of asthmatics (c.f., Kinsman, 
et al., 1980) and several groups of investigators have 
postulated the existence of subgroups (Purcel, et al.,
1968; Rackemanne, 1928), these differentiations have not 
been shown to be of clinical importance.
It is possible however, that in attempting to find 
differences between the groups, we have not measured the 
correct variables. In this study, three dimensions of 
functioning were assessed: affective/emotional responding, 
clinical symptomatology, and cognitions regarding illness 
and asthma. Using multivariate procedures, no significant 
differences between the two groups were found. The lack of
a difference between the groups on measures of 
affective/emotional functioning (i.e., anxiety, depression) 
may be accounted for by the selection process. All
subjects had to have at least minimal problems with asthma
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related symptomatology. Having a serious chronic illness 
without any necessary exacerbations (stress related or not) 
is known to be associated with increased emotional distress 
(Frericks, et al., 1982; Thompson & Thompson, 1984). This 
fact combined with the selection process which required 
both groups to have active disease related problems may 
account for the absence of any significant differences in 
emotional functioning.
It was quite surprising to find no differences between 
stress responders and stress nonresponders on measures of 
asthma severity. Given the conditioning process that is 
presumed to play a major role among stress responder 
asthmatics, it was expected that the presence of 
"conditioned asthma problems" on top of the individuals' 
regular asthma difficulties would have resulted in 
increased clinical symptomatology for the stress 
responders. The lack of a significant difference between 
these groups suggests that conditioning processes may not 
be as important as once presumed. An alternative 
hypothesis however, is that conditioning processes affect 
both groups independently of stress responsiveness. These 
hypotheses need further elaboration and testing in future 
studies. Given the lack of a difference between the two 
groups on measures of affective/emotional responding and
49
clinical symptomatology, it was not surprising to find no 
differences between the groups on a measure of cognitive 
dimensions related to illness and asthma.
The ASC panic-fear scale accounted for very little 
variance in the difference between asthma symptomatology on 
days of high stress and asthma symptomatology on days of 
low stress. The addition of anxiety and depression scores 
to the regression model did add to the amount of variance 
that could be accounted for but not enough to result in an 
overall significant effect for the regression model. Thus, 
these scales are not predictive of differences in asthma 
symptomatology as measured in this study. In addition, 
these variables were unable to successfully discriminate 
between stress responders and stress nonresponders. The 
model using panic-fear alone successfully categorized only 
58.8% while adding the anxiety and depression scores 
increased the success rate to only 61.8%. Therefore, these 
variables appear to have limited predictive value.
While it was possible to separate out the subjects in 
the study into the two groups using correlational 
procedures, the asthma symptoms did not covary within 
individuals. Thus, on days of high stress, one subject 
might react with more coughing and activity restriction 
whereas another may react more with wheezing and
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interference in their daily routine. This has important 
implications, both clinical and theoretical.
Theoretically, the effect of response stereotypy (Lacey & 
Lacey, 1958) may help to explain the differences.
According to this theory, the pattern of responsiveness is 
different for each individual. This was initially applied 
to psychophysiological variables to help explain why one 
individual responds to stress more with cardiovascular 
changes while another responds more with pulmonary changes. 
However, it appears that a similar phenomenon occurs within 
a specific disease (i.e., asthma) as well as serving as an 
explanation for differences between different diseases.
The different pattern of stress relatedness within 
asthmatics may be of importance. Individuals who have 
stress related increases in wheezing and interference with 
their daily routine as opposed to coughing and activity 
restriction may be different physiologically as well as 
behaviorally. Clinically, it becomes important to measure 
illness severity across different dimensions and using more 
than just one symptom. This is especially important in 
asthma and other illnesses which can have numerous effects 
and in which the severity of the illness is a combination 
of multiple factors (e.g., diabetes, renal disease). This 
point must be kept in mind not only for this and future
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studies, but also when reading and interpreting previous 
experiments which have been reported in the literature. 
Studies which have found no relation between stress and 
illness symptomatology (Spittle and Sears, 1984) may have 
measured only one aspect of illness severity.
In conclusion, the present study indicated that 
although we are able to distinguish between stress 
responders and stress nonresponders on the basis of 
correlations between their self-reported number of 
stressors and their asthma symptoms, we were unable to 
discern any significant differences between the groups. 
Before additional studies in this area are conducted, there 
is a basic psychometric question which needs to be 
resolved: that of the reliability and validity of the 
responder/nonresponder distinction. To do this, future 
studies need to first test the stability of the 
distinction. Will someone defined as a stress responder 
today be so defined using data collected 1 month later, 2 
months.later, or 6 months later? Validity data could come 
in the form of biochemical, psychophysiological, and other 
laboratory diagnostic techniques.
Finally, it would then be important to determine the 
usefulness of this distinction. What are the differences 
between the groups? Is one group more likely to have skills
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which make them better able to cope with stress while the 
other to utilize medical services more frequently? 
Identifying these groups without identifying any 
differences between them questions the utility and validity 
of the distinction. In this paper, two univariate ANOVAs 
were significant at the .05 level. These were the ASC 
panic-fear scale and the External Control scale of the 
RIOS. However, the multivariate analyses in which these 
variables were included were nonsignificant, thus rendering 
these scales unable to be interpreted. Whether the 
differences on these scales represents true differences 
between the groups or are spurious results is a question 
which needs to be addressed in future research studies. In 
addition, future studies need to define precisely what 
constitutes a true increase in illness severity and what 
specific symptomatology should be included. In any event, 
it seems imperative that we continue measuring multiple 
aspects of functioning including physiological, behavioral, 
cognitive, and emotional components. Only in this way can 
we more effectively elucidate the stress-illness relation.
Table 1
Means and Standard Deviations of all variables
Mean S.
Wheeze 1.76 1 .
Activity Restriction 1.74 0.
Coughing 1.98 0.
Interference with Routine 1.73 1.
Frequency of Stresors 17.63 17.
MMPI-D 68.74 10.
MMPI-Pt 64.77 12.
ASC Panic-Fear 2.79 0.
Optimism 3.46 0.
Neg. Staff Regard 1.86 0.
Internal Awareness 4.16 0.
External Control 2.40 0.

















Intercorrelation matrix for all variables
(n = 3 9 )
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Intercorrelation matrix for all variables













Nega. Inter. Exter. Stigma
. 1 392 -.0371 -.2187 -.0945
.3980 .8225 .1811 .5671
.1478 .2765 -.2042 -.3842









Correlation of DSI-frequency with asthma symptoms
for subjects in stress responder group
Sub Wheeze Activity Cough Interference
1 .382 .604* . 1 55 .493*
2 .755* .616* .000 .085
3 .445* .500* .321 .355
4 .625* .428 .615* .267
5 -.090 .597* -.456* .597*
6 .521* .452* .194 .476*
7 .518* .440* .326 .288
8 .195 .205 .437* .438*
9 .228 .802* -.345 .729*
10 .448* -.505* .000 .447*
1 1 -.053 .521* -.224 .470*
1 2 .478* .580* .051 .462*
1 3 -.102 .579* .579* -.247
14 .302 .638* .493* .281
15 .009 .494* . 1 05 .434*






















Correlation of DSI-frequency with asthma symptoms
for subjects in stress nonresponder group
Wheeze Activity Cough Interference
.080 .181 .354 .026
.348 -.1 52 .000 .000
.052 .264 .185 .396
-.034 .204 .195 .066
.187 .034 .000 .000
-. 1 96 .000 .237 .000
.000 .351 .000 .000
.000 -.1 04 .000 -.094
.000 .000 .000 .000
-.144 -.279 .000 -.279
-.237 -.290 -.246 -.278
.120 -.093 .102 -.059
.000 -.059 .000 .204
. 000 .041 .112 .095
-.122 .098 .000 .009
-.137 .410 .073 .000
-.410 .213 .401 -.232
.070 .202 -.101 -.044
-.282 .220 -.317 .311
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Table 7
Correlation of DSI-frequency with asthma symptoms
for subjects in neither group
Sub Wheeze Activity Cough Interference
1 -.081 -.145 -.484* -.303
2 .261 .439* .376 .118
3 .056 .556* .219 .374
4 .462* .405 . 1 52 .148
5 -.251 .584* -.1 52 -.062
* significant at the .05 level
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Table 8
MANCOVA and univariate ANCOVAS to test for differences 
between stress responders and stress nonresponders on
affective/emotional measures
df F value p value
Overall MANOVA 3, 29 0.34 > . 10
MMPI-D 2, 30 0.15 > .10
MMPI-Pt 2 , 30 0.37 > . 1 0
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Table 9
MANOVA and univariate ANOVAs to test for differences
between
stress responders and stress nonresponders on measures 
of clinical symptomatology
df
Overall MANOVA 6, 27
Wheezing 1, 32
Activity Restriction 1, 32
Coughing 1, 32
Interference 1, 32
Number of Stressors 1, 32











. 1 0  
. 1 0 
. 1 0  
.05 




MANOVA and univariate ANOVAs to test for differences
between
stress responders and stress nonresponders on scores from
the subscales of the RIOS
df F value p value
Overall MANOVA 5, 28 1.09 > .10
Optimism 1, 32 0.01 > .10
Negative Staff Regard 1, 32 0.27 > .10
Internal Awareness 1, 32 0.09 > .10
Psychological Stigma 1/32 0.52 > .10
External Control 1, 32 5.17 < .03
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Table 11
Regression analyses using only the panic-fear scale
Variable F Value p value R-Square
Wheeze 0.09 .761 .0025
Activity 1 .79 .189 .0461
Cough 0.16 .692 .0043
Interference 2.46 .126 .0623
Table 12
Regression analyses using panic-fear, MMPI-D, and
Variable B Weight F Value p value
Wheeze 0.12 .884
panic-fear -0.018 0.02 .886
MMPI-D -0.005 0.14 .709
MMPI-Pt -0.001 0.00 .953
Activity 2.85 .051
panic-fear -0.274 2.89 .098
MMPI-D -0.008 0.18 .676
MMPI-Pt 0.036 5.07 .031
Cough 0.47 .704
panic-fear 0.062 0.45 .505
MMPI-D -0.007 0.41 .524
MMPI-Pt -0.003 0.11 .743
Interference 1.42 .253
panic-fear -0.312 2.79 .104
MMPI-D -0.006 0.07 .791









Discriminant analysis based on panic-fear score


























Discriminant analysis based on panic-fear, MMPI-C
MMPI-PT
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Below are listed a variety of events that may be viewed as stressful or unpleasant. 
Read each item carefully and decide whether or not that event occurred within the 
past 24 hours. If the event did not occur, place an H X " in the space next to that 
item. If the event did occur, indicate the amount of stress that it caused you by 
placing a number from zero to 7 in the space next to that item (see numbers below). 
Please answer as honestly as you can so that we nay obtain accurate information.
X * did not occur (past 24 hrs.) 3 =* caused a little stress 6 * caused very
1 ■ occurred but was not stressful 4 = caused some stress much stress
2 « caused very little stress 5 = caused much stress 7 = caused me to
panic
1. Performed poorly at task
2. Performed poorly due to others_
3. Thought about unfinished work
4. Hurried to meet deadline
5. Interrupted during task / 
activity
6. Someone spoiled your completed 
task
7. Did something you are 
unskilled at
8. Unable to complete a task
9. Was unorganized
10. Criticized or verbally 
attacked
11. Ignored by others
12. Spoke or performed in public
13. Dealt with rude waiter/ 
waitress/salesperson
14. Interrupted while talking
15. Was forced to socialize
16. Someone broke a promise/ 
appointment
17. Competed with someone
18. Was stared at
19. Did not hear from someone 
you expected to hear from




23. Had your sleep disturbed
24. Forgot something
25. Feared illness/pregnancy
26. Experienced illness/physical 
discomfort
27. Someone borrowed something 
without your permission
28. your property was damaged
29. Had minor accident (broke 
something, tore clothing)
30. Thought about the future
31. Ran out of food/personal 
article
32. Argued with spouse/boyfriend/ 
girlfriend _ _ _
33. Argued with another person ____
34. Waited longer than you wanted ____
35. Interrupted while thinking/ 
relaxing _ _ _
36. Someone "cut" ahead of you in
a line ____
37. Performed poorly at sport/game _ _ _
38. Did something that you did not
want to do _ _ _
39. Unable to complete all plans
for today___________________________
40. Had car trouble ____
41. Had difficulty in traffic _ _ _
42. Money problems _ _
43. Store lacked a desired item ____
44. Misplaced something _ _
45. Bad weather ____
46. Unexpected expenses (fines,
traffic ticket, etc.)________________
47. Had confrontation with an 
authority figure________________ ____
48. Heard some bad news ____
49. Concerned over personal appearance
50. Exposed to feared situation or 
object ___
51. Exposed to upsetting TV show,
movie, book _ _
52. "Pet peeve" violated (someone
fails to knock, etc.)_______________ '
53.'Failed to understand something ___
54. Worried about another's problems ___
55. Experienced narrow escape from 
danger.____________________________
56. Stopped unwanted personal habit 
(overeating, smoking, nailbiting) ___
57. Had problem with kid(s) ___
58. Was late for work/appointment _ _ _










, Daily Symptom Record
Name:   PATE
1. LAST NIt;iir: Cood night, did not wake up at all......................U
Woke up 1-2 Limes due to wheezing, coughing............ 1
Woke up 3-4 limes due to wheezing, coughing............ 2
Wuke up 5-6 times due to wheezing, couching............ 3
Vcrv had night, awake all or most ot' r.ijjht.............4
2 .  WHEEZE TODAY: None......................................................0
0-4 hours............................................... 1
i 4-8 hours................................................ 2
1 8-12 hours............................................... 3
12-16 hours............................................. 4
_________ _ _  16 hours or more..........   ««5
j. ACTIVITY TOUAi: Normal, activities not restricted at all.......... 0
Slightly restricted, but able tu perform
most of my usual activities......................... 1
Fairly restricted, had to limit some activities...2
Aloe restricted, had to limit must activities 3
Extremely restricted, had co ^et n u i d i c a l h e l ^ ^ ^ 4




^Indicate whether coughing prodm eu ;:nutu:r.-Yes or No___
5. INTERFERENCE U'llil ACTIVITY: How many times did you have to stop
"during an activity or eliminate an activity because* your asthma 
was interfering with what you could do? Once y»m record how many 





6 times or more, could not Jo anything all Jay......................4
6. Rate on the following scale how much discomfort your asthma caused today.
0 I 2 3 4 5 6 ”  8 ” 9~ 10
NONE NO MORE WORST
THAN USUAL DAY EVER
7. Huw man" v i gar**”:tov» did *'*>u smoke tod-v ’
O
PLEASE NOTE:
Copyrighted materials in this document have 
not been filmed at the request of the author. 
They are available for consultation, however, 
in the author’s  university library.
These consist of pages:
91-94, Appendix C - Asthma Sympton Checklist
95-97, Appendix D - Respiratory Illness Opinion Survey
UMI
Appendix E
"MULTIDISCIPLINARY APPROACH TO THE MANAGEMENT OF SEVERE ASTHMATICS"—  ,RHONE-NO-<5041-358-1060 - . , - . , » , vINFORMED CONSENT ' . V ;
I , . , understand th a t I have a serious condition
called  bronchial asthma. This has been thoroughly explained to me by my doctors. I 
freely and w illingly consent to be a participant In a research project tha t 1s 
Investigating a m ultidisciplinary approach to the management of bronchial asthma. The 
project is  being directed by Or. J .  0. Martin, Associate Professor of Medicine,
Louisiana State University School of Medicine.
As a research subject, I have been asked to:
a) Undergo a thorough medical examination.
b) Participate In a psychological assessment procedure during which I will 
be administered the Asthma Symptom Checklist, the Respiratory Illness 
Opinion Survey, the Minnesota Multi phasic Personality Inventory, and a 
general information questionnaire. This will take a t lea s t two hours 
to complete.
c) Participate 1n a group treatment program conducted by the 
Earl K. Long Respiratory Department and Psychology Service.
d) Keep dally records as to my asthma symptoms and the medication I take.
e) Keep daily records as to the stressful events th a t I experience 
throughtout the day. I will be provided a form on which to record th is  
Information.
f) Agree to partic ipa te  1n future follow-up investigations.
I understand that the risks Involved are no more than those associated with being a 
patient under normal circumstances. I am aware th a t my doctors will do everything 
possible to prevent complications but these s t i l l  may occur. The costs of unforeseen 
complications must be met by me.
I understand that I may withdraw my participation a t any time without 
consequences. In addition, any Information th a t I provide will be kept In confidence.
I f  th is  information is  presented publlcally (journal a r t ic le s , conferences,), no 
Information will be identified  with me personally.
I realize  th a t I have the rig h t to ask questions a t any time and to have these 
questions answered to my sa tisfac tion .
I have read and thoroughly understand th is  consent form and I have been given a 
copy for my records.
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